About Us

Eyenuk, Inc.

logo

Eyenuk, Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance.

Harnessing the power of AI to analyze retinal images was the inspiration of Eyenuk Founder & CEO Kaushal Solanki. During his own health scare, Solanki faced a four-month long wait to see a specialist about his retinal scans. His own father’s struggle with diabetes led Solanki to better understand the risks of diabetic retinopathy, as well as the shortage of qualified professionals to address the issue.

Our Mission

Eyenuk is accelerating the world’s transition to predictive and preventative healthcare with innovative, AI-driven diagnostic solutions.

Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease.

Group 7
EyenukVisionMission_Visual_20190118_noTM

Meet the management team

Pic_Kaushal_final_1
Kaushal Solanki
PhD, UCSB
Founder & CEO
Kaushal founded Eyenuk in 2010 as he saw a large unmet need in early detection of life- and vision-threatening diseases. Over the last ten years, Kaushal led Eyenuk to rapid success, including $16 million infusion from investments and grants, multiple patents, numerous peer-reviewed publications with superior clinical results, and key regulatory approvals around the world. Kaushal authored 40+ scientific papers and abstract presentations and is recognized as a thought-leader in artificial intelligence in healthcare. He likes music and plays Tabla – an Indian percussion instrument. [LinkedIn]
Pic_Frank_final_1
Pic_Chaithanya_final_1
Pic_Sandeep_final-768x768_1
Pic_Malavika_final1_1
Pic_greg_final_1
Frank Cheng
MBA, Vanderbilt
President & CCO
Frank joined Eyenuk in 2019 by bringing his 25-year experience in leading large-scale commercialization of digital health innovations in robotic surgery, digital diagnostics, HCIT, clinical diagnostics and diagnostic imaging. Earlier in his career, Frank held executive positions with five publicly-traded companies (GE, Roche, Hill-Rom, Stereotaxis and Cogstate) and led two venture-backed companies as CEO. Frank built and led large global teams to drive commercial growth, strategic partnerships, customer success & operations, reimbursement justification, regulatory clearance and corporate planning. [LinkedIn]
Chaithanya Ramachandra
PhD, USC
Head of R&D
Chaithanya joined Eyenuk in 2013 and is spearheading Eyenuk’s research and development initiatives. Chaithanya contributed significantly to Company’s advanced research which led to development of Company’s proprietary EyeArt platform for autonomous diseases detection with superior clinical performance. Chaithanya’s research interests are computer vision, machine learning and computational neuroscience. He loves gardening and grows organic produce in his backyard. [LinkedIn]
Sandeep Bhat
PhD, UCSB
Head of Engineering
Sandeep joined Eyenuk in 2013 and has been leading Eyenuk’s engineering team. Over the years, the engineering team lead by Sandeep have championed software innovations and successfully executed Company’s product roadmap by launching product offerings on-time, to-spec, while ensuring regulatory compliance. Sandeep’s research interests are machine learning, computer vision, and image processing. He is a technophile, an avid photographer, and loves playing squash. [LinkedIn]
Malavika Bhaskaranand
PhD, UCSB
Head of Product Management
Malavika joined Eyenuk in 2013 and is in charge of Eyenuk’s product management efforts. Malavika has been instrumental in defining and refining Company’s product roadmap by bridging advanced research breakthroughs with most pressing market needs. Malavika successfully led team and executed the 15-center, prospective, pivotal clinical trial for the EyeArt autonomous diabetic retinopathy detection system after gaining FDA approval for the study protocol. Malavika’s research interests include machine learning, video and image processing, computer vision, and information theory. She is a trained Carnatic singer and loves Indian classical music. [LinkedIn]
Greg Russell
MPhil, UoM
Head of Clinical Development
Greg joined Eyenuk in 2016 and is leading Eyenuk’s clinical development efforts. Prior to Eyenuk, Greg had over 15 years of program management and grading experience supporting the UK National Health Service Diabetic Eye Screening Program. Greg is one of the most experienced graders related to diseases such as diabetic retinopathy, AMD, glaucoma, cataract and retinal angiography, and he also interim managed over 11 diabetic retinopathy screening programs internationally. Greg is working towards a PhD in Ophthalmology. He plays the guitar, and is a keen photographer. [LinkedIn]

Clinical Collaborators

2_2
1_1
DrOanaDumitrascu-pic
3_3
4_4
5_5
Dr. Srinivas Sadda, MD
President & CSO,
Doheny Eye Institute, Los Angeles, CA
Dr. Jorge Cuadros, OD, PhD
CEO of EyePACS LLC.,
Assistant Clinical Professor,
Director of Clinical Infomatics Research, Optometry,
University of California, Berkeley, CA.
Dr. Oana M. Dumitrascu, MD, MSc
Assistant Professor, Neurology
Cedars Sinai, Los Angeles, CA
Dr. Lauren P. Daskivich, MD, MSHS
Director, Ophthalmology and Eye Health Programs
Los Angeles County Department of Health Services (LAC DHS),
Los Angeles, CA
Dr. Todd Margolis, MD, PhD
Alan A. and Edith L. Wolff Distinguished Professor and Chairman,
Ophthalmology and Visual Sciences,
Washington University School of Medicine,
St. Louis, MO
Dr. Andrew Boulton, MD, DSc (Hon), FRCP
Professor of Medicine,
Division of Medicine,
The University of Manchester, U.K
Group-symbol

Join our Team

Headstart your career with us.
Find out more about working at Eyenuk, click the button below.